CAN1012 in Pre-Malignant DCIS and LCIS

This is a Phase I/Ib study evaluating CAN1012 in patients with ductal carcinoma in situ and lobular carcinoma in situ.

Trial Details

NCT ID
NCT07408856
Phase
PHASE1
Sponsor
Providence Health & Services
Status
RECRUITING
Cancer Type
Lobular Carcinoma Breast Cancer
Interventions
  • CAN1012
Locations (sample)
  • Portland, Oregon, United States|45.52345,-122.67621

Key Eligibility Criteria

  • Male or female patients with DCIS or LCIS found on core biopsy.
  • Tumor types allowed:
  • Biopsy-identified DCIS or LCIS comprising a single lesion ≥ 1 cm and ≤ 5 cm in size by imaging (mammogram or MRI or ultrasound (US)) without eviden…
  • Age 18 years or above with ability to give informed consent, comply with the protocol, and sign a study-specific consent document.

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Lobular Carcinoma Breast Cancer Trials on Trialify →